2.77
+0.005(+0.18%)
Currency In USD
| Previous Close | 2.76 |
| Open | 2.75 |
| Day High | 2.81 |
| Day Low | 2.68 |
| 52-Week High | 5.8 |
| 52-Week Low | 2.2 |
| Volume | 650,894 |
| Average Volume | 1.55M |
| Market Cap | 274.62M |
| PE | -5.42 |
| EPS | -0.51 |
| Moving Average 50 Days | 2.79 |
| Moving Average 200 Days | 3.79 |
| Change | 0.01 |
If you invested $1000 in Aquestive Therapeutics, Inc. (AQST) since IPO date, it would be worth $172.27 as of May 09, 2025 at a share price of $2.765. Whereas If you bought $1000 worth of Aquestive Therapeutics, Inc. (AQST) shares 5 years ago, it would be worth $476.72 as of May 09, 2025 at a share price of $2.765.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
GlobeNewswire Inc.
May 05, 2025 11:00 AM GMT
WARREN, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science an
Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET
GlobeNewswire Inc.
May 01, 2025 11:00 AM GMT
WARREN, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science an
Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
GlobeNewswire Inc.
Apr 09, 2025 11:00 AM GMT
WARREN, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science a